Listed

Pyxis Oncology, Inc.

PYXSNasdaqCIK 1782223HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$11.0m, Q4 FY2025
Operating income−$26.0m, Q2 FY2026
Net income−$25.3m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reported16.1Revenue, Q1 FY2024, three months to 2024-03-31$16.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-15, accession 0000950170-25-071996.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-14, accession 0000950170-25-108906. Derived: 6-month figure less the 3-month figure.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-03, accession 0001193125-25-261696. Derived: 9-month figure less the 6-month figure.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-23, accession 0001193125-26-118532. Derived: 12-month figure less the 9-month figure.Report this figurenot reported2.8Revenue, Q2 FY2025, three months to 2025-06-30$2.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-14, accession 0000950170-25-108906.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-03, accession 0001193125-25-261696. Derived: 9-month figure less the 6-month figure.Report this figure11.0Revenue, Q4 FY2025, three months to 2025-12-31$11.0m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-23, accession 0001193125-26-118532. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Cost of revenue$mnot reportednot reported0.5Cost of revenue, Q1 FY2024, three months to 2024-03-31$475.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-15, accession 0000950170-25-071996.Report this figure0.0Cost of revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-14, accession 0000950170-25-108906. Derived: 6-month figure less the 3-month figure.Report this figure0.0Cost of revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-03, accession 0001193125-25-261696. Derived: 9-month figure less the 6-month figure.Report this figure0.0Cost of revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-23, accession 0001193125-26-118532. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m14.7Research and development, Q3 FY2023, three months to 2023-09-30$14.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-124602.Report this figure11.6Research and development, Q4 FY2023, three months to 2023-12-31$11.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-18, accession 0000950170-25-040771. Derived: 12-month figure less the 9-month figure.Report this figure13.0Research and development, Q1 FY2024, three months to 2024-03-31$13.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0000950170-25-071996.Report this figure14.0Research and development, Q2 FY2024, three months to 2024-06-30$14.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0000950170-25-108906.Report this figure17.7Research and development, Q3 FY2024, three months to 2024-09-30$17.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figure14.0Research and development, Q4 FY2024, three months to 2024-12-31$14.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-23, accession 0001193125-26-118532. Derived: 12-month figure less the 9-month figure.Report this figure17.0Research and development, Q1 FY2025, three months to 2025-03-31$17.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-222843.Report this figure17.1Research and development, Q2 FY2025, three months to 2025-06-30$17.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure17.8Research and development, Q3 FY2025, three months to 2025-09-30$17.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figure21.7Research and development, Q4 FY2025, three months to 2025-12-31$21.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-23, accession 0001193125-26-118532. Derived: 12-month figure less the 9-month figure.Report this figure20.0Research and development, Q1 FY2026, three months to 2026-03-31$20.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-222843.Report this figure16.1Research and development, Q2 FY2026, three months to 2026-06-30$16.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure
Operating income$m(25.4)Operating income, Q3 FY2023, three months to 2023-09-30−$25.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-124602.Report this figure(17.8)Operating income, Q4 FY2023, three months to 2023-12-31−$17.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-18, accession 0000950170-25-040771. Derived: 12-month figure less the 9-month figure.Report this figure(5.6)Operating income, Q1 FY2024, three months to 2024-03-31−$5.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0000950170-25-071996.Report this figure(20.0)Operating income, Q2 FY2024, three months to 2024-06-30−$20.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-108906.Report this figure(23.8)Operating income, Q3 FY2024, three months to 2024-09-30−$23.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figure(40.1)Operating income, Q4 FY2024, three months to 2024-12-31−$40.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-118532. Derived: 12-month figure less the 9-month figure.Report this figure(22.9)Operating income, Q1 FY2025, three months to 2025-03-31−$22.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222843.Report this figure(19.8)Operating income, Q2 FY2025, three months to 2025-06-30−$19.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure(23.5)Operating income, Q3 FY2025, three months to 2025-09-30−$23.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figure(18.3)Operating income, Q4 FY2025, three months to 2025-12-31−$18.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-118532. Derived: 12-month figure less the 9-month figure.Report this figure(24.4)Operating income, Q1 FY2026, three months to 2026-03-31−$24.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222843.Report this figure(26.0)Operating income, Q2 FY2026, three months to 2026-06-30−$26.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reported0.3Income tax, Q2 FY2025, three months to 2025-06-30$283.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-03, accession 0001193125-25-261696. Derived: 9-month figure less the 6-month figure.Report this figure1.1Income tax, Q4 FY2025, three months to 2025-12-31$1.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-23, accession 0001193125-26-118532. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure
Net income$m(23.0)Net income, Q3 FY2023, three months to 2023-09-30−$23.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-124602.Report this figure(15.6)Net income, Q4 FY2023, three months to 2023-12-31−$15.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-18, accession 0000950170-25-040771. Derived: 12-month figure less the 9-month figure.Report this figure(3.3)Net income, Q1 FY2024, three months to 2024-03-31−$3.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-108906.Report this figure(17.3)Net income, Q2 FY2024, three months to 2024-06-30−$17.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-108906.Report this figure(21.2)Net income, Q3 FY2024, three months to 2024-09-30−$21.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figure(35.6)Net income, Q4 FY2024, three months to 2024-12-31−$35.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-118532. Derived: 12-month figure less the 9-month figure.Report this figure(21.2)Net income, Q1 FY2025, three months to 2025-03-31−$21.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure(18.4)Net income, Q2 FY2025, three months to 2025-06-30−$18.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure(22.0)Net income, Q3 FY2025, three months to 2025-09-30−$22.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figure(18.1)Net income, Q4 FY2025, three months to 2025-12-31−$18.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-118532. Derived: 12-month figure less the 9-month figure.Report this figure(23.3)Net income, Q1 FY2026, three months to 2026-03-31−$23.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure(25.3)Net income, Q2 FY2026, three months to 2026-06-30−$25.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure
Diluted EPS$ per share(0.56)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-124602.Report this figurenot reported(0.06)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0000950170-25-071996.Report this figure(0.29)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0000950170-25-108906.Report this figure(0.35)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figurenot reported(0.35)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-222843.Report this figure(0.30)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure(0.35)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figurenot reported(0.37)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-222843.Report this figure(0.40)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure
Basic EPS$ per share(0.56)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.56 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-124602.Report this figurenot reported(0.06)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0000950170-25-071996.Report this figure(0.29)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0000950170-25-108906.Report this figure(0.35)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figurenot reported(0.35)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-222843.Report this figure(0.30)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure(0.35)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figurenot reported(0.37)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-222843.Report this figure(0.40)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure

Balance sheet

Cash and equivalents$18.9m, Q2 FY2026
Shareholders' equity$11.4m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m14.7Cash and equivalents, Q3 FY2023, at 2023-09-30$14.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-124602.Report this figure9.7Cash and equivalents, FY2023, at 2023-12-31$9.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-18, accession 0000950170-25-040771.Report this figure28.0Cash and equivalents, Q1 FY2024, at 2024-03-31$28.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0000950170-25-071996.Report this figure25.1Cash and equivalents, Q2 FY2024, at 2024-06-30$25.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0000950170-25-108906.Report this figure12.1Cash and equivalents, Q3 FY2024, at 2024-09-30$12.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figure19.5Cash and equivalents, FY2024, at 2024-12-31$19.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-23, accession 0001193125-26-118532.Report this figure12.8Cash and equivalents, Q1 FY2025, at 2025-03-31$12.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001193125-26-222843.Report this figure10.7Cash and equivalents, Q2 FY2025, at 2025-06-30$10.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure8.9Cash and equivalents, Q3 FY2025, at 2025-09-30$8.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figure15.4Cash and equivalents, FY2025, at 2025-12-31$15.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure5.8Cash and equivalents, Q1 FY2026, at 2026-03-31$5.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001193125-26-222843.Report this figure18.9Cash and equivalents, Q2 FY2026, at 2026-06-30$18.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure
Current assets$m139Current assets, Q3 FY2023, at 2023-09-30$139.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-060354.Report this figure125Current assets, FY2023, at 2023-12-31$124.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-18, accession 0000950170-25-040771.Report this figure172Current assets, Q1 FY2024, at 2024-03-31$172.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059099.Report this figure161Current assets, Q2 FY2024, at 2024-06-30$161.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0000950170-24-097073.Report this figure149Current assets, Q3 FY2024, at 2024-09-30$148.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-124602.Report this figure132Current assets, FY2024, at 2024-12-31$132.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-23, accession 0001193125-26-118532.Report this figure112Current assets, Q1 FY2025, at 2025-03-31$111.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-071996.Report this figure100.0Current assets, Q2 FY2025, at 2025-06-30$100.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108906.Report this figure83.1Current assets, Q3 FY2025, at 2025-09-30$83.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figure72.1Current assets, FY2025, at 2025-12-31$72.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure45.6Current assets, Q1 FY2026, at 2026-03-31$45.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-222843.Report this figure36.7Current assets, Q2 FY2026, at 2026-06-30$36.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure
Total assets$m187Total assets, Q3 FY2023, at 2023-09-30$186.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0000950170-23-060354.Report this figure174Total assets, FY2023, at 2023-12-31$173.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-18, accession 0000950170-25-040771.Report this figure220Total assets, Q1 FY2024, at 2024-03-31$220.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0000950170-24-059099.Report this figure208Total assets, Q2 FY2024, at 2024-06-30$208.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0000950170-24-097073.Report this figure195Total assets, Q3 FY2024, at 2024-09-30$195.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-124602.Report this figure157Total assets, FY2024, at 2024-12-31$157.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-23, accession 0001193125-26-118532.Report this figure136Total assets, Q1 FY2025, at 2025-03-31$135.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0000950170-25-071996.Report this figure123Total assets, Q2 FY2025, at 2025-06-30$123.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0000950170-25-108906.Report this figure106Total assets, Q3 FY2025, at 2025-09-30$105.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figure91.5Total assets, FY2025, at 2025-12-31$91.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure64.3Total assets, Q1 FY2026, at 2026-03-31$64.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001193125-26-222843.Report this figure54.9Total assets, Q2 FY2026, at 2026-06-30$54.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure
Current liabilities$m28.3Current liabilities, Q3 FY2023, at 2023-09-30$28.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-060354.Report this figure25.8Current liabilities, FY2023, at 2023-12-31$25.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-18, accession 0000950170-25-040771.Report this figure14.1Current liabilities, Q1 FY2024, at 2024-03-31$14.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059099.Report this figure16.9Current liabilities, Q2 FY2024, at 2024-06-30$16.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0000950170-24-097073.Report this figure20.3Current liabilities, Q3 FY2024, at 2024-09-30$20.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-124602.Report this figure17.7Current liabilities, FY2024, at 2024-12-31$17.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-23, accession 0001193125-26-118532.Report this figure14.4Current liabilities, Q1 FY2025, at 2025-03-31$14.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-071996.Report this figure17.7Current liabilities, Q2 FY2025, at 2025-06-30$17.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108906.Report this figure19.4Current liabilities, Q3 FY2025, at 2025-09-30$19.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figure21.1Current liabilities, FY2025, at 2025-12-31$21.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure16.5Current liabilities, Q1 FY2026, at 2026-03-31$16.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-222843.Report this figure27.5Current liabilities, Q2 FY2026, at 2026-06-30$27.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure
Total liabilities$m48.7Total liabilities, Q3 FY2023, at 2023-09-30$48.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0000950170-23-060354.Report this figure48.0Total liabilities, FY2023, at 2023-12-31$48.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-18, accession 0000950170-25-040771.Report this figure36.1Total liabilities, Q1 FY2024, at 2024-03-31$36.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0000950170-24-059099.Report this figure38.6Total liabilities, Q2 FY2024, at 2024-06-30$38.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0000950170-24-097073.Report this figure41.6Total liabilities, Q3 FY2024, at 2024-09-30$41.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-124602.Report this figure36.4Total liabilities, FY2024, at 2024-12-31$36.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-23, accession 0001193125-26-118532.Report this figure32.8Total liabilities, Q1 FY2025, at 2025-03-31$32.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0000950170-25-071996.Report this figure35.6Total liabilities, Q2 FY2025, at 2025-06-30$35.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0000950170-25-108906.Report this figure36.8Total liabilities, Q3 FY2025, at 2025-09-30$36.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figure38.1Total liabilities, FY2025, at 2025-12-31$38.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure33.0Total liabilities, Q1 FY2026, at 2026-03-31$33.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001193125-26-222843.Report this figure43.5Total liabilities, Q2 FY2026, at 2026-06-30$43.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure
Shareholders' equity$m138Shareholders' equity, Q3 FY2023, at 2023-09-30$137.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-124602.Report this figure126Shareholders' equity, FY2023, at 2023-12-31$125.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-23, accession 0001193125-26-118532.Report this figure184Shareholders' equity, Q1 FY2024, at 2024-03-31$184.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0000950170-25-108906.Report this figure170Shareholders' equity, Q2 FY2024, at 2024-06-30$169.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figure154Shareholders' equity, Q3 FY2024, at 2024-09-30$153.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figure121Shareholders' equity, FY2024, at 2024-12-31$120.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure103Shareholders' equity, Q1 FY2025, at 2025-03-31$103.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure87.6Shareholders' equity, Q2 FY2025, at 2025-06-30$87.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure68.8Shareholders' equity, Q3 FY2025, at 2025-09-30$68.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figure53.4Shareholders' equity, FY2025, at 2025-12-31$53.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure31.3Shareholders' equity, Q1 FY2026, at 2026-03-31$31.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure11.4Shareholders' equity, Q2 FY2026, at 2026-06-30$11.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure

Cash flow

Operating cash flow−$18.2m, Q2 FY2026
Capital expenditure$0, Q4 FY2025
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(17.6)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$17.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-124602. Derived: 9-month figure less the 6-month figure.Report this figure(15.3)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$15.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-18, accession 0000950170-25-040771. Derived: 12-month figure less the 9-month figure.Report this figure(20.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$20.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0000950170-25-071996.Report this figure(3.0)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0000950170-25-108906. Derived: 6-month figure less the 3-month figure.Report this figure(14.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$14.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001193125-25-261696. Derived: 9-month figure less the 6-month figure.Report this figure(19.3)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$19.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001193125-26-118532. Derived: 12-month figure less the 9-month figure.Report this figure(22.5)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$22.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-222843.Report this figure(17.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$17.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-347913. Derived: 6-month figure less the 3-month figure.Report this figure(13.3)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$13.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001193125-25-261696. Derived: 9-month figure less the 6-month figure.Report this figure(10.4)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$10.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001193125-26-118532. Derived: 12-month figure less the 9-month figure.Report this figure(26.0)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$26.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-222843.Report this figure(18.2)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$18.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-347913. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q3 FY2023, three months to 2023-09-30$61.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000950170-24-124602. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-18, accession 0000950170-25-040771. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$237.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0000950170-25-071996.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0000950170-25-108906. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0001193125-25-261696. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001193125-26-118532. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reported0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001193125-26-118532. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)63.99m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares32.6Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3032,561,228 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0000950170-23-060354.Report this figure35.4Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3135,351,671 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0000950170-24-059099.Report this figure38.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3038,389,123 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0000950170-24-097073.Report this figure41.3Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3041,331,806 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-124602.Report this figure51.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3151,289,284 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0000950170-25-071996.Report this figure60.5Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3060,495,675 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0000950170-25-108906.Report this figure60.7Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3060,715,041 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figure61.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3161,048,948 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-222843.Report this figure61.9Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3061,918,826 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure62.6Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3062,557,386 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001193125-25-261696.Report this figure63.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3163,469,850 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-222843.Report this figure64.0Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3063,991,609 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure

Shares outstanding: 83.41mShares outstanding, period not labelled, at 2026-08-1283,408,050 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-347913.Report this figure at Aug 12, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.